Intrinsic order and disorder in the Bcl-2 member Harakiri: Insights into its proapoptotic activity

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Barrera Vilarmau, Susana ^a   Obregón, Patricia ^a   de Alba, Eva ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BH3 PROTEIN; HARAKIRI PROTEIN; MONOMER; PROTEIN BCL 2; PROTEIN BCL X; UNCLASSIFIED DRUG; WATER; APOPTOSIS REGULATORY PROTEIN; HRK PROTEIN, HUMAN; MUTANT PROTEIN; PEPTIDE;

ALPHA HELIX; APOPTOSIS; ARTICLE; BINDING ASSAY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; MICELLIZATION; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN CONFORMATION; PROTEIN DEFECT; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STATIC ELECTRICITY; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METABOLISM; MICELLE; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; CELL SURVIVAL; CIRCULAR DICHROISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 79959558144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021413     Document Type: Article

References (58)

1. Kerr JF, Wyllie AH, Currie AR, (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257.
2. Li J, Yuan J, (2008) Caspases in apoptosis and beyond. Oncogene 27: 6194-6206.
3. Adams JM, Cory S, (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326.
4. Danial NN, Korsmeyer SJ, (2004) Cell Death. Cell 116: 205-219.
5. Oltvai ZN, Korsmeyer SJ, (1994) Checkpoints of dueling dimers foil death wishes. Cell 79: 189-192.
6. Reed JC, (2000) Mechanisms of Apoptosis. Am J Pathol 157: 1415-1430.
7. David CS, Huang DCS, Strasser A, (2000) BH3-only proteins: essential initiators of apoptotic cell death. Cell 103: 839-842.
8. Lomonosova E, Chinnadurai G, (2009) BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27: S2-S19.
9. Chou JJ, Li H, Salvesen GS, Yuan J, Wagner G, (1999) Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96: 615-624.
10. McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D, (1999) Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96: 625-634.
11. Hinds MG, Smits C, Fredericks-Short R, Risk JM, Bailey M, et al. (2007) Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ 14: 128-136.
12. Bocharov EV, Pustovalova YE, Pavlov KV, Volynsky PE, Goncharuk MV, et al. (2007) Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger. J Biol Chem 282: 16256-16266.
13. Sattler M, Liang H, Nettesheim DG, Meadows RP, Harlan JE, et al. (1997) Structure of Bcl-XL/Bak peptide complex: recognition between regulators of apoptosis. Science 275: 983-986.
14. Petros AM, Nettesheim DG, Wang Y, Olejniczak ET, Meadows RP, et al. (2000) Rationale for Bcl-XL/Bad peptide complex formation from structure, mutagenesis and biophysical studies. Protein Sci 9: 2528-2534.
15. Liu Q, Moldoveanu T, Sprules T, Matta-Camacho E, Mansur-Azzam N, et al. (2010) Apoptotic regulation by MCL-1 through hetero-dimerization. J Biol Chem 285: 19615-19624.
16. Horne WS, Boersma MD, Windsor MA, Gellman SH, (2008) Sequence-based design of α/β-Peptide foldamers that mimic BH3 domains. Angew Chem Int Ed 47: 2853-2856.
17. Vogler M, Dinsdale D, Dyer MJ, Cohen GM, (2009) Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 16: 360-367.
18. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, et al. (2004) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183-192.
19. Inohara N, Ding L, Chen S, Núñez G, (1997) Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J 16: 1686-1694.
20. Bernabeu A, Guillén J, Pérez-Berná AJ, Moreno MR, Villalaín J, (2007) Structure of the C-terminal domain of the proapoptotic protein Hrk and its interaction with model membranes. Biochem Biophys Acta 1768: 1659-1670.
21. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, et al. (2005) Differential targeting of prosurvival Bcl-2 Proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393-403.
22. Sborgi L, Barrera-Vilarmau S, Obregón P, de Alba E, (2010) Characterization of a novel interaction between Bcl-2 members Diva and Harakiri. PLoS ONE 5: e15575.
23. Rost B, Yachdav G, Liu J, (2004) The PredictProtein Server. Nucl Acids Res 32: W321-W326 (Web Server issue).
24. Certo M, Del Gaizo Moore V, Nishino M, Wei G, Korsmeyer S, et al. (2006) Mitochondria primed by death signals determine cellular addiction to antiapoptotic Bcl-2 family members. Cancer Cell 9: 351-365.
25. de Alba E, Jiménez MA, Rico M, Nieto JL, (1996) Conformational investigation of designed short linear peptides able to fold into beta-hairpin structures in aqueous solution. Fold Des 1: 133-144.
26. Bruix M, Muñoz V, Campos-Olivas R, del Bosque JR, Serrano L, et al. (1997) Characterisation of the isolated Che Y C-terminal fragment (79-129). Exploring the structure/stability/folding relationships of the α/β parallel protein Che Y. Eur J Biochem 243: 384-392.
27. Wishart DS, Bigam CG, Holm A, Hodges RS, Sykes BD, (1995) 1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J Biomol NMR 5: 67-81.
28. Wüthrich K, (1986) NMR of Proteins and Nucleic Acids. NMR of Proteins and Nucleic Acids.
29. Lee EF, Sadowsky JD, Smith BJ, Czabotar PE, Peterson-Kaufman KJ, et al. (2009) High-resolution structural characterization of a helical alpha/beta-peptide foldamer bound to the anti-apoptotic protein Bcl-xL. Angew Chemie Intl Ed 48: 4318-4322.
30. Uversky VN, (2010) Seven lessons from one IDP structural analysis. Structure 18: 1069-1071.
31. Shoemaker BA, Portman JJ, Wolynes PG, (2000) Speeding molecular recognition by using the folding funnel: The fly-casting mechanism. Proc Natl Acad Sci USA 97: 8868-8873.
32. Sugase K, Dyson HJ, Wright, PE, (2007) Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature 447: 1021-1027.
33. Tompa P, Fuxreiter M, (2008) Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. Trends Biochem Sci 33: 2-8.
34. Ragusa MJ, Dancheck B, Critton DA, Nairn AC, Page R, et al. (2010) Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites. Nat Struct Mol Biol 17: 459-466.
35. Masotti L, Spinsni A, Urry DW, (1980) Conformational studies on the gramicidin A transmembrane channel in lipid micelles and liposomes. Cell Biophys 2: 241-249.
36. Pervushin KV, Orekhov VY, Popov AI, Musina LY, Arseniev AS, (1994) Three-dimensional structure of (1-7l) bacterioopsin solubilized in methanol-chloroform and SDS micelles determined by l5N-lH heteronuclear NMR spectroscopy. Eur J Biochem 219: 571-583.
37. Schnell JR, Chou JJ, (2008) Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451: 591-595.
38. Rath A, Johnson RM, Deber CM, (2007) Peptides as transmembrane segments: decrypting the determinants for helix-helix interactions in membrane proteins. Biopolymers 88: 217-232.
39. Spera S, Bax A, (1991) Empirical correlation between protein backbone conformation and Cα and Cβ. 13C nuclear magnetic resonance chemical shifts. J Am Chem Soc 113: 5490-5492.
40. Yau W-M, Wimley WC, Gawrish K, White SH, (1998) The preference of tryptophan for membrane interfaces. Biochemistry 37: 14713-14718.
41. Pinheiro AS, Marsh JA, Forman-Kay JD, Peti W, (2011) Structural signature of the MYPT1-PP1 interaction. J Am Chem Soc 133: 73-80.
42. de Alba E, (2009) Structure and interdomain dynamics of apoptosis-associated speck-like protein containing a CARD (ASC). J Biol Chem 284: 32932-32941.
43. Bogner C, Leber B, Andrews DW, (2010) Apoptosis: embedded in membranes. Curr Opin Cell Biol 22: 1-7.
44. Bax A, Grzesiek S, (1993) Methodological advances in protein NMR. Accounts Chem Res 26: 131-138.
45. Cavanagh J, Fairbrother WJ, Palmer AG (3rd), Rance M, Skelton NJ, (2006) in Protein NMR spectroscopy: Principles and practice (Academic Press, San Diego).
46. Bax A, Davis AG, (1985) MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Reson 65: 355-360.
47. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
48. Garrett DS, Powers R, Gronenborn AM, Clore GM, (1991) A common sense approach to peak picking in two-, three-, and four-dimensional spectra using computer analysis of contour diagrams. J Magn Reson 95: 214-220.
49. Goddard TD, Kneller DG, San Francisco University of California SPARKY 3.
50. Nilges M, (1993) A calculation strategy for the structure determination of symmetric dimers by 1H NMR. Proteins 17: 297-309.
51. Cornilescu G, Delaglio F, Bax A, (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 13: 289-302.
52. Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM, (2003) The Xplor-NIH NMR molecular structure determination package. J Magn Reson 160: 65-73.
53. Koradi R, Billeter M, Wüthrich K, (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graphics 14: 51-55.
54. Laskowski RA, Rullmann JA, MacArthur MW, Kaptein R, Thornton JM, (1996) AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8: 477-496.
55. Rohl CA, Chakrabartty A, Balwin RL, (1996) Helix propagation and N-cap propensities of the amino acids measured in alanine-based peptides in 40 volume percent trifluoroethanol. Protein Sci 5: 2623-2637.
56. Meyers JK, Pace CN, Scholtz JM, (1997) Helix propensities are identical in proteins and peptides. Biochemistry 36: 10923-10929.
57. Feller SE, Yin D, Pastor RW, MacKerell AD Jr, (1997) Molecular dynamics simulation of unsaturated lipids at low hydration: Parametrization and comparison with diffraction studies. Biophys J 73: 2269-2279.
58. Sadqi M, de Alba E, Pérez-Jiménez R, Sánchez-Ruíz JM, Muñoz V, (2009) A designed protein as experimental model of primordial folding. Proc Natl Acad Sci USA 106: s4127-4132.